MediFind
Condition

Epidermolysis Bullosa

Active Clinical Trials

Clinical Trial
Biological
  • Status: Recruiting
  • Study Type: Biological
  • Participants: 24
  • Start Date: June 9, 2020
A Pivotal Phase 3 Study of FCX-007 (Genetically-Modified Autologous Human Dermal Fibroblasts) for Recessive Dystrophic Epidermolysis Bullosa
Clinical Trial
Other
  • Status: Recruiting
  • Study Type: Other
  • Participants: 100
  • Start Date: March 2, 2020
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Epidermolysis Bullosa
Clinical Trial
Biological
  • Status: Recruiting
  • Study Type: Biological
  • Participants: 15
  • Start Date: January 10, 2020
VIITAL: A Phase 3 Study of EB-101 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Clinical Trial
Other
  • Status: Active, not recruiting
  • Study Type: Other
  • Participants: 1
  • Start Date: December 10, 2019
SASS 3: Self-Assembled Skin Substitute (SASS) for the Treatment of Epidermolysis Bullosa
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 6
  • Start Date: October 31, 2019
Optimization of Intravenous Gentamicin Treatment to Restore Functional Laminin 332 in JEB Patients With Nonsense Mutations
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 40
  • Start Date: April 18, 2019
A Neurokinin-1 Receptor Antagonist for the Treatment of Pruritus in Patients With Epidermolysis Bullosa
Clinical Trial
Biological
  • Status: Recruiting
  • Study Type: Biological
  • Participants: 40
  • Start Date: January 16, 2019
An Interventional, Multicenter, Single Arm, Phase I/IIa Clinical Trial to Investigate the Efficacy and Safety of Allo-APZ2-EB on Epidermolysis Bullosa (EB)